ISPE 2020 Mid-Year Meeting Cancelled
The International Society for Pharmacoepidemiology (ISPE) has made the difficult decision, after careful consideration and comprehensive evaluation of currently available information related to the novel coronavirus (COVID-19) outbreak, to cancel the Mid-Year Meeting, originally scheduled for April 18-21 in Orlando, Florida. The meeting will not be rescheduled this year.
ISPE has been closely monitoring the rapidly increasing domestic and worldwide developments during the last several weeks related to COVID-19. This evidence-based decision was made after a thorough review and discussion of all factors impacting the meeting, including the U.S. government's recent announcement of new restrictions on international travelers to enter the U.S.; the imposition of travel restrictions issued by U.S. government agencies, academic institutions, and pharmaceutical and biotech companies; and the counsel of infectious disease experts. It is clear that all of these elements significantly affect the ability of delegates, speakers, and exhibitors to participate fully in the Mid-Year Meeting.
The health, safety, and security of all Mid-Year Meeting attendees and the communities they serve are ISPE's highest priorities. While we believe that the decision to cancel the meeting is the correct one to safeguard our meeting participants from further potential exposure to the coronavirus, we also understand that this is a disappointing one for everyone involved. We thank all of our volunteer leaders, exhibitors and sponsors for their patience and support at this time.
Within the next two weeks, full refunds will be processed for everyone currently registered for the meeting back to the original method of payment; if we encounter problems refunding registrants, we will contact you.
Additional information regarding hotel reservation cancellations will be announced shortly. Please contact your airline carrier directly and follow their guidelines regarding the changing or cancellation of flights.
Our sincere sympathies go out to everyone impacted by this global health crisis.
Aging in The Sunshine State: Rising to The Challenges in Pharmacoepidemiology.
#ISPEMY2020
April 18-21, 2020, Loews Royal Pacific Resort, Orlando, Florida
Keynote Speaker: Dr. Michael Steinman, University of California, San Francisco
Topic: Deprescribing and Pharmacoepidemiology - Opportunity, Power, Humility
Dr. Steinman is Professor of Medicine in the Division of Geriatrics at the University of California, San Francisco and the San Francisco VA Medical Center. He is a national leader in identifying and improving the quality of medication prescribing in clinically complex older adults, while also maintaining an active clinical practice in the geriatrics clinic and inpatient general medicine service at the San Francisco VA Medical Center. Dr. Steinman's research program focuses on improving how doctors prescribe medications for older adults, and is supported by grants from the National Institutes of Health and other funders He also has a strong interest in mentorship and supporting career development for junior investigators.
2020 ISPE Mid-Year Planning Committee
Almut Winterstein, FISPE, President of ISPE, UF College of Pharmacy, Chair
Juan Hincapie-Castillo, UF College of Pharmacy, Co-Chair
Josh Brown, UF College of Pharmacy
Christian Hampp, US Food and Drug Administration
Caitlin Knox, Chair ISPE Education Committee, Regeneron Pharmaceuticals
Jenny Lo-Ciganic, UF College of Pharmacy
Zach Marcum, University of Washington
Elle Saine, University of Pennslyvania
Maribel Salas, Daiichi Sankyo
Stephan Schmidt, UF College of Pharmacy
Shannon Sperati, ISPE Staff
James Vrac, ISPE Executive Secretary
Scott Vouri, UF College of Pharmacy
Caroline Walsh, Chair of the Student Council, RCSI
Jenny Wei, UF College of Pharmacy
Sponsors
Gold
RTI Health Solutions
Endorsed By
